Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Strenkoski

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Pharmacokinetics|October 1, 1993
Cefpirome clinical pharmacokineticsL C Strenkoski, D E Nix
Journal of Clinical Pharmacology|November 24, 1998
Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteersL C Strenkoski-Nix, A Forrest, J J Schentag, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 1998
Pharmacodynamic interactions of antibiotics alone and in combinationJ J Schentag, L C Strenkoski-Nix, D E Nix, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 31, 2000
Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjectsL C Strenkoski-Nix, J Ermer, S DeCleene, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Pharmacodynamic modeling of the in vivo interaction between cefotaxime and ofloxacin by using serum ultrafiltrate inhibitory titersD E Nix, J H Wilton, J Hyatt, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot studyW J Tremaine, A Brzezinski, J A Katz, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Pharmacokinetics|October 1, 1993
Cefpirome clinical pharmacokineticsL C Strenkoski, D E Nix
Journal of Clinical Pharmacology|November 24, 1998
Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteersL C Strenkoski-Nix, A Forrest, J J Schentag, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 1998
Pharmacodynamic interactions of antibiotics alone and in combinationJ J Schentag, L C Strenkoski-Nix, D E Nix, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 31, 2000
Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjectsL C Strenkoski-Nix, J Ermer, S DeCleene, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Pharmacodynamic modeling of the in vivo interaction between cefotaxime and ofloxacin by using serum ultrafiltrate inhibitory titersD E Nix, J H Wilton, J Hyatt, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot studyW J Tremaine, A Brzezinski, J A Katz, et al.
Pageof 1